Blood screening involves testing blood samples for infectious agents, genetic disorders, and other health conditions to ensure safety in blood transfusion, organ transplantation, and diagnosis. This market includes technologies and services used to detect pathogens such as HIV, hepatitis B and C viruses, syphilis, and other blood-borne diseases. Increasing demand for safe blood supply, rising awareness about blood-borne infections, and advancements in screening technologies are driving the global blood screening market growth.
The global blood screening market was valued at USD 2.99 billion in 2023 and is anticipated to grow at a CAGR of 11.6% from 2024 to 2033.
2. Market Dynamics
Drivers:
-
Increasing Demand for Safe Blood Transfusions: Growing volume of blood transfusions worldwide due to surgeries, trauma care, and chronic diseases.
-
Rising Prevalence of Blood-Borne Infections: HIV, Hepatitis B & C, and other infectious diseases increase the need for stringent screening.
-
Technological Advancements: Introduction of rapid, automated, and highly sensitive screening methods.
-
Government Regulations and Policies: Strict guidelines and mandatory screening protocols boost market demand.
Restraints:
-
High Cost of Advanced Screening Technologies: Cost-prohibitive equipment limits accessibility in developing countries.
-
Lack of Infrastructure in Low-Resource Settings: Insufficient blood screening facilities in rural and underserved areas.
-
False Positives/Negatives: Accuracy concerns affect reliability and trust in screening processes.
Opportunities:
-
Emerging Markets Expansion: Rising healthcare expenditure and blood donation awareness in Asia-Pacific and Latin America.
-
Point-of-Care Testing (POCT): Growing adoption of portable blood screening devices.
-
Integration with Digital Health: AI and machine learning enhancing screening efficiency and data management.
3. Segment Analysis
By Technology:
By Application:
-
Blood Banks
-
Hospitals and Clinics
-
Diagnostic Laboratories
-
Research Institutes
By Screening Type:
By End User:
-
Public Blood Banks
-
Private Blood Banks
By Region:
-
North America
-
Europe
-
Asia-Pacific
-
Latin America
-
Middle East & Africa
4. Some of the Key Market Players
-
Abbott Laboratories
-
Roche Diagnostics
-
bioMérieux SA
-
Grifols, S.A.
-
Danaher Corporation
-
Thermo Fisher Scientific
-
Bio-Rad Laboratories, Inc.
-
Ortho Clinical Diagnostics
-
F. Hoffmann-La Roche Ltd.
-
Wadsworth Center
5. Report Description
This report presents a comprehensive analysis of the Global Blood Screening Market, detailing key market trends, growth drivers, challenges, and future opportunities. It provides segmentation by technology, application, screening type, and geography. The report covers technological innovations, regulatory frameworks, and competitive strategies adopted by leading players. Forecasts through 2030 offer insights for stakeholders to capitalize on emerging market dynamics.
Request Sample PDF @ https://www.thebrainyinsights.com/enquiry/sample-request/14155
6. Table of Contents
-
Executive Summary
-
Market Introduction
-
Research Methodology
-
Market Dynamics
-
4.1 Drivers
-
4.2 Restraints
-
4.3 Opportunities
-
Technological Innovations and Trends
-
Segment Analysis
-
6.1 By Technology
-
6.2 By Application
-
6.3 By Screening Type
-
6.4 By End User
-
6.5 By Region
-
Regulatory Landscape
-
Competitive Landscape
-
Strategic Recommendations and Forecast (2025–2030)
-
Appendix
Locked
